Stay updated on Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial page.

Latest updates to the Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial page
- CheckyesterdayChange DetectedAdded recruitment status text 'No longer looking for participants' and new guidance sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') along with a new 'Intervention/Treatment' heading (replacing 'Intervention / Treatment'). The page revision was updated to v3.6.0, replacing v3.5.5.SummaryDifference0.1%

- Check8 days agoChange DetectedThe change updates the document revision log to v3.5.5 and removes the previous v3.5.4, indicating a newer version of the study documentation has been published.SummaryDifference0.0%

- Check15 days agoChange DetectedThe page now includes a more detailed ORR definition evaluated by IRRC using RECIST v1.1 for intermediate/poor-risk patients, with associated time frames, and adds PDFs for the Study Protocol, Protocol Amendment 06, and the Statistical Analysis Plan; the previous Investigator-assessed ORR description and its time frame were removed.SummaryDifference0.3%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedA new revision identifier (v3.5.4) appears, indicating a small update to the page's revision history rather than a change to the study content.SummaryDifference0.0%

- Check44 days agoChange DetectedThe Taiwan location entry was updated from Taoyuan District to Taoyuan in the study's locations list.SummaryDifference0.0%

- Check51 days agoChange DetectedClinicalTrials.gov’s page footer revision version was updated from v3.5.2 to v3.5.3, indicating a technical/site-version change rather than an update to the study record itself.SummaryDifference0.0%

Stay in the know with updates to Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial page.